Pancreatic Cancer Research

ResearcherSheng Jing HospitalActive in the last 2 years

Kai Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7535-1313, 0009-0004-2018-1969; OpenAlex author ID A5115592837. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. m6A reader YTHDF2 orchestrates CD8+ T cell infiltration to promote pancreatic cancer progression and predicts clinical outcome. Co-author DOI 10.1016/j.intimp.2024.113079↗
  2. Transcriptional regulatory network and protein-protein interaction to reveal the mechanism of pancreatic cancer. Last author DOI 10.1007/s11033-013-2872-0↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mengqi Song · 1 shared paper, 2024 · strength 0.23
  2. Weidong Guo · 1 shared paper, 2024 · strength 0.23
  3. Zhen Tan · 1 shared paper, 2024 · strength 0.23
  4. Bing Han · 1 shared paper, 2014 · strength 0.06
  5. Hongli Sun · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.